Profitability Ratios
| Ratio |
Value |
| GP Margin |
78.1% |
| EBIT Margin |
21.0% |
| EBITDA Margin |
23.6% |
| Operating Margin |
27.0% |
| Pretax Margin |
21.0% |
| Cont. Ops Margin |
17.4% |
| Net Margin |
17.7% |
| Bottom Line Margin |
17.7% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
3.72 |
| Quick Ratio |
3.09 |
| Solvency Ratio |
0.366 |
| Cash Ratio |
1.62 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.63 |
| Forward PEG |
-0.63 |
| Price/Book |
4.82 |
| Price/Sales |
8.22 |
| Price/FCF |
37.34 |
| Price/Op Cash Flow |
31.25 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0515 |
| Debt/Equity |
0.0682 |
| Debt/Capital |
0.0639 |
| Long-Term Debt/Capital |
0.0547 |
| Financial Leverage |
1.32 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
1.25 |
| Operating Cash Flow Ratio |
0.880 |
| Operating Cash Flow/Sales |
26.3% |
| Free Cash Flow/Operating Cash Flow |
83.7% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
49.49 |
| Interest Coverage |
0.0000 |
| Short-Term Operating Cash Flow Coverage |
65.11 |
| Operating Cash Flow Coverage |
2.26 |
| Capital Expenditure Coverage |
6.13 |
| Dividend + Capital Expenditure Coverage |
6.13 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
10.38 |
| EPS |
1.836 |
| Debt/Share |
1.2062 |
| Cash/Share |
7.23 |
| Book Value/Share |
17.68 |
| Tangible BV/Share |
12.72 |
| Equity/Share |
17.68 |
| Operating Cash Flow/Share |
2.728 |
| Capital Expenditure/Share |
0.445 |
| FCF/Share |
2.283 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.843 |
| Earnings Before Tax/EBIT |
0.778 |
| Price/Fair Value |
4.82 |
| Debt/Market Cap |
0.0125 |
| Effective Tax Rate |
17.0% |
| Enterprise Value Multiple |
33.31 |
EW - Edwards Lifesciences Corporation